METHOD FOR DETERMINING IN VIVO SILICONE EXPOSURE

摘要

A method for determining silicone implant failure in a patient includes the steps of collecting lymphocytes from the patient and dividing the lymphocytes into a control group and a test group. The lymphocytes in the test group are exposed to a silicone antigenic determinant. After incubation, DNA and/or protein synthesis is then quantitatively measured in both the control and test groups. The results are then compared. A relative increase in DNA and/or protein synthesis by the lymphocytes in the test group indicates hypersensitivity resulting from silicone implant failure.